Skip to content

Neuroscience and the Near-Death Experience: Roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins

Karl Jansen

Medical Hypotheses January 1, 1990 DOI: 10.1016/0306-9877(90)90048-j via OpenAlex

Summary

AI-generated from the abstract

The near-death experience (NDE) is a dissociative mental state with characteristic features that can be reproduced by ketamine, which acts at sigma sites and blocks NMDA-linked PCP receptors to reduce ischemic damage. Endogenous ligands, alpha and beta-endopsychosin, have been detected for these receptors, suggesting an explanation for some NDEs: the endopsychosins may be released in abnormal quantity to protect neurons from ischemic and other excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Topics Ketamine
Keywords Phencyclidine Nmda receptor Neuroscience Sigma receptor
Citations 96
Key finding Endopsychosins may be released in abnormal quantity to protect neurons from ischemic and excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions.

Abstract

The Near-Death Experience (NDE) is a dissociative mental state with characteristic features. These can be reproduced by ketamine which acts at sigma sites and blocks N-methyl-D-aspartate (NMDA) linked phencyclidine (PCP) receptors to reduce ischaemic damage. Endogenous ligands, alpha and beta-endopsychosin, have been detected for these receptors which suggests an explanation for some NDE's: the endopsychosins may be released in abnormal quantity to protect neurons from ischaemic and other excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions.

Explore topics

Comments

No comments yet.

Log in to comment